Mobile app risk in healthcare is becoming business risk

At a glance

What this is: This is an analysis of why mHealth and healthtech app risk is a safety, privacy and business issue, with emphasis on lifecycle controls, third-party dependencies and AI-driven governance gaps.

Why it matters: It matters because IAM, PAM and broader identity programmes increasingly have to account for application trust, developer access, third-party code and AI usage inside regulated healthcare delivery.

By the numbers:

• Only 44% of developers are reported to follow security best practices for secrets management, exposing a significant developer behaviour gap.

👉 Read NowSecure's analysis of mobile app risk in healthcare and healthtech

Context

Mobile app risk in healthcare is not only a software assurance problem. When apps connect patients to care, devices, insurance services or protected health information, a defect can affect safety, privacy and regulatory standing at the same time. The primary issue is not whether testing exists, but whether governance covers the full lifecycle from design to post-market monitoring.

The article’s central thread is that modern healthtech apps accumulate risk through third-party SDKs, embedded AI features and developer workflow gaps. That makes mobile app security a governance problem as much as an engineering one, and it intersects with identity where app trust depends on access, authentication, secrets, and control of who can change what in production.

Key questions

Q: How should healthcare teams govern mobile app risk across the full lifecycle?

A: Healthcare teams should govern mobile app risk from architecture through post-market monitoring, because safety, privacy and compliance are connected in regulated apps. That means design review, testing in build and release, continuous monitoring after deployment, and clear ownership for every high-risk component. Lifecycle governance reduces the chance that a defect becomes a patient safety or trust event.

Q: Why do third-party SDKs and APIs make mobile app security harder to control?

A: Third-party components make mobile app security harder because teams inherit code, update paths and data access they do not fully control. Once integrated, those components can create hidden trust boundaries and supply-chain exposure. The practical response is component inventory, SBOM coverage and evidence-based approval before sensitive data or workflows are exposed.

Q: What do security teams get wrong about AI features inside cloud security platforms?

A: They often assume AI features are only about better analytics, when the bigger issue is whether those features influence access, response, or automation decisions. Once AI is connected to cloud operations, it becomes part of the identity and governance model. Teams should ask who approved the workflow, what it can do, and how it is audited.

Q: Who is accountable when a connected health app mishandles patient data?

A: Accountability should be shared across the organisation that granted access, the vendor operating the app, and the team responsible for consent and logging. If policy cannot show who approved the access, under what terms, and how it will be revoked, the governance model is incomplete.

Technical breakdown

Why healthcare mobile apps create a dual safety and security problem

mHealth apps can mediate clinical workflows, so a security flaw can become a safety event. In regulated environments, data integrity, availability and confidentiality are all part of the risk picture because broken app logic, tampered data or blocked access can affect care delivery. The operational mistake is treating appsec as a release gate rather than a lifecycle discipline. Safety-driven industries need design-time threat modelling, testing during build and deployment, and post-market monitoring after release.

Practical implication: map mobile app risk to the product lifecycle, not just the release pipeline.

How third-party SDKs and APIs expand mobile app attack surface

Third-party components import risk because teams inherit code, update cycles and hidden dependencies they do not fully control. A software bill of materials helps establish what is actually inside the app, while static and dynamic testing show how those components behave in context. The key governance failure is blind trust in vendor libraries or APIs after integration. In healthcare, that blind spot matters because a component defect can affect sensitive data flows, regulatory evidence and downstream patient trust.

Practical implication: vet dependencies before integration and maintain a living SBOM for every release.

Why embedded AI features create new governance blind spots

AI inside mobile apps can come from code assistants, embedded model features or third-party SDKs, and teams often discover it late. That creates uncertainty about training data, model drift and the controls surrounding feature updates. For identity and governance teams, the relevant issue is not only whether AI exists, but who can influence it, what data it sees and whether its behaviour is auditable. In regulated healthtech, undocumented AI usage is a control gap, not a novelty.

Practical implication: inventory AI usage in mobile apps and tie it to approval, data and change controls.

Threat narrative

Attacker objective: The attacker objective is to exploit hidden trust in mobile app components to reach sensitive health data or disrupt care-related functionality.

1. Entry occurs through third-party SDKs, APIs or embedded AI features that are integrated into the mobile app without full governance visibility.
2. Escalation follows when those components access sensitive health data, device workflows or production logic beyond the original trust boundary.
3. Impact is patient privacy loss, degraded safety, delayed approvals and business disruption when defects reach production or post-market users.

NHI Mgmt Group analysis

Healthcare appsec is now a governance discipline, not just a testing discipline. The article shows that mobile app risk in safety-driven industries spans patient safety, privacy, compliance and business continuity. That means the control objective is broader than catching defects before release. It is about lifecycle accountability, evidence of component trust and continuous monitoring after deployment. Practitioners should treat app security as part of operational governance, not a narrow engineering checkpoint.

Third-party component risk is a hidden trust problem. SDKs, APIs and libraries create a dependency chain that teams often cannot observe fully once integrated. That is a classic trust-boundary issue, and in identity terms it mirrors the problem of granting standing privilege to systems you do not continuously validate. Hidden dependency trust gap: once a component is embedded, governance often assumes it remains what it was at integration time, which is exactly where risk accumulates. Practitioners should re-evaluate how they approve, inventory and monitor third-party components.

AI in healthtech apps creates a documentation and accountability deficit before it creates a model risk problem. The article’s AI section is strongest when read as a governance warning: teams cannot protect what they have not inventoried. That aligns with NIST AI RMF GOVERN and MAP functions because the first failure is often ownership, scope and traceability. In identity-heavy programmes, the same logic applies to AI features that handle sensitive data or trigger actions. Practitioners should require explicit accountability for every AI-enabled feature.

Developer buy-in is a control layer, not a soft skill. The article correctly notes that tools fail when developers treat them as blockers. In practice, secure delivery depends on workflow integration, usable feedback and shared responsibility between product security and engineering. That is consistent with NIST CSF and NIST SP 800-53 control families focused on access, configuration and monitoring, but the deeper lesson is cultural: governance fails when teams cannot operationalise it. Practitioners should measure adoption, not just tool deployment.

What this signals

Hidden dependency trust gap: healthtech teams will keep inheriting security risk through SDKs, APIs and embedded AI unless they treat component approval as a governance process, not a procurement event. That shifts the programme from release testing to continuous validation of what is actually running in production.

The next maturity step is to connect appsec evidence to identity and access control, especially where developers, service accounts and CI pipelines can change production behaviour. Where mobile apps touch sensitive health data, the control question is who can alter data flows, model behaviour and release artefacts, not just whether code passed scanning.

Programme leaders should also expect AI-enabled features to expand the need for inventory, traceability and change control. When AI usage is undocumented, the organisation cannot prove what data was processed, what logic changed, or who approved it, which makes compliance and incident response harder to defend.

For practitioners

• Inventory mobile app dependencies and AI features Create a release-level inventory of every SDK, API, library and embedded AI capability, then tie each item to an owner, change record and risk rating. Use the inventory to spot undocumented data access and unsupported update paths before release. Suggested anchor: release-level inventory of every SDK
• Build lifecycle controls into mobile app risk management Move appsec checks earlier and later in the lifecycle by combining design review, static and dynamic testing, post-release monitoring and incident response. For regulated healthcare apps, map each control to the product stage where patient safety or data integrity could fail. Suggested anchor: post-release monitoring
• Require evidence for third-party trust decisions Do not accept component attestations at face value. Ask for SBOM coverage, dependency update cadence, vulnerability disclosure terms and testing evidence for each vendor component that touches sensitive data or device workflows. Suggested anchor: SBOM coverage
• Make developer adoption measurable Track whether developers actually use security testing, training and review workflows rather than assuming policy compliance. Measure participation in hands-on testing, fix turnaround and the percentage of releases that pass through embedded security controls without manual workarounds. Suggested anchor: hands-on testing

Key takeaways

• Mobile app security in healthcare is really a safety, privacy and governance problem, not just a code-quality problem.
• Third-party components and embedded AI create hidden trust boundaries that teams cannot manage without inventory, evidence and lifecycle controls.
• Practitioners should move appsec from one-time testing to continuous governance across design, release and post-market monitoring.

Key terms

• Mobile App Risk Management: The discipline of governing mobile application exposure across code, dependencies, data access, and runtime behaviour. It goes beyond testing for bugs and asks whether the app can safely handle sensitive information, AI-enabled functions, and third-party components without expanding access or trust beyond what the business intended.
• Software Bill of Materials: A software bill of materials is an inventory of the components and dependencies used in an application. It helps teams identify what they shipped, but it becomes most useful when paired with source verification, signature checks, and policy enforcement for third-party code.
• Embedded AI: Embedded AI is an AI feature built into an existing application rather than delivered as a separate tool. It matters because the app may already be approved, while the new model behavior changes what data is processed, retained, or sent to third parties.
• Post-market monitoring: Post-market monitoring is the ongoing collection and review of system behaviour after deployment so emerging risks, drift, and incidents can be detected and corrected. In regulated AI programmes, it is part of the evidence chain and must connect operational telemetry back to governance decisions.

What's in the full article

NowSecure's full post covers the operational detail this analysis intentionally leaves for the source:

• The full discussion of mobile app risk management across safety-driven healthcare workflows and regulated product lifecycles.
• The detailed handling of static and dynamic mobile application security testing, manual pen testing and bug bounty integration.
• The practical approach to SBOM use, third-party component review and AI usage documentation in healthtech apps.
• The operational lessons from Velentium Medical on developer training, incident response and approval timelines.

👉 NowSecure's full discussion covers the appsec workflow, component risk and AI governance detail behind the summary here.

Deepen your knowledge

NHI Mgmt Group covers identity security, NHI governance, and agentic AI through independent research, practitioner guides, and the NHI Foundation Level course, the industry's only accredited NHI security programme. Explore the course if your programme needs a stronger operating model for identity, secrets and access governance.